ABCL SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

NEWForm 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 9, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 11, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 24, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2025

News

TYPE

HEADLINE

FILED AT

8-K

NEWAbCellera Reports Q3 2026 Business Results and Announces $200 Million Offering

Nov 9, 2026

8-K

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering

Aug 13, 2026

8-K

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635

Aug 10, 2026

8-K

AbCellera to Announce Phase 2 Top-Line Results for ABCL635

Aug 7, 2026

8-K

AbCellera Reports Q2 2026 Financial Results and New Strategic Collaborations

Aug 5, 2026

8-K

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases

Jul 29, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Aug 13, 2026

424B5

PENDING FIXED PRICE OFFERING | Offering amount: $200,000,000 | Bank: Jefferies, J.P. Morgan, Cantor, UBS Investment Bank, BMO Capital Markets

Aug 11, 2026

424B3

12,000,000 Common Shares-

Feb 15, 2022

424B3

12,000,000 Common Shares-

Dec 7, 2021

424B3

12,000,000 Common Shares-

Dec 6, 2021

424B3

12,000,000 Common Shares-

Nov 12, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 24, 2026

S-3ASR

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 27, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 27, 2025

S-8

Registration

Feb 20, 2024

S-8

Registration

Feb 21, 2023

POS AM

Registration

Jul 22, 2022

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Hayden Michael R (Reporting)

Aug 24, 2026

Montalbano John S. (Reporting)

Aug 18, 2026

Booth Andrew (Reporting)

Aug 14, 2026

Hayden Michael R (Reporting)

Aug 14, 2026

Hayden Michael R (Reporting)

Aug 13, 2026

Seely Lynn (Reporting)

Jul 6, 2026

Other

TYPE

HEADLINE

FILED AT

AbCellera Biologics Inc. ABCL · SEC Filings